SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances raised FY2026 revenue outlook, supported by stronger demand for Amtagvi and Proleukin, is driving the rally, with analyst upgrades adding momentum. Traders are celebrating the commercial progress while debating whether short-covering is amplifying the move, and many are looking ahead to lung-cancer data.

AST SpaceMobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an intellectual property and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

A newly adopted change-of-control severance policy has fueled buyout and strategic-partnership speculation, though traders disagree on whether it signals anything beyond routine executive protections. The chatter is tempered by frustration over the lack of shipment and launch updates for BlueBird satellites, alongside sharp price swings and mixed bullish and bearish reactions.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. Its products include Gvoke, Keveyis, and Recorlev. Gvoke is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

A report that Lundbeck is exploring a possible acquisition of Xeris has driven a burst of attention and trading volume. Traders are debating the buyout speculation after Xeris said it is not for sale, with some seeing takeover potential and others criticizing the companys response.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas selection for a U.S. Army program to develop next-generation 10 kV silicon carbide devices is drawing attention as a validation of its technology and domestic manufacturing capabilities. Traders are divided: some see longer-term potential, while others question the impact because the award is a prototype program with no disclosed financial terms and may not bring meaningful near-term revenue.

Fair Isaac Corp. engages in the provision of decision management solutions. It operates through the Software and Scores segments. The Software segment includes pre-configured analytic and decision management solutions designed for a specific type of business need or process. The Scores segment focuses on business-to-business scoring solutions and services, business-to-consumer scoring solutions and services including myFICO solutions for consumers and associated professional services. The company was founded by Bill Fair and Earl Isaac in 1956 and is headquartered in San Jose, CA.

Fair Isaac Corp.

Fair, Isaac Corp.

FICO is under pressure after FHFA moved to let Fannie Mae and Freddie Mac use VantageScore alongside FICO under a unified mortgage pricing grid, raising concerns that competition could erode its mortgage-scoring advantage and pricing power. Traders are divided between viewing the selloff as an overreaction and a buying opportunity, and seeing it as a lasting threat to FICOs moat.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reports of improving user growth have fueled optimism about Reddits growth outlook, while traders remain divided over the stocks weak, volatile performance. Bears point to executive share sales and uncertainty around Googles AI data-licensing relationship; bulls argue advertising growth and user metrics support the long-term case.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

Rising long-term Treasury yields, fueled by inflation concerns, oil-price pressures, deficits and expectations of further Fed tightening, are weighing on TLT. Traders are split between expecting more bond losses and seeing the selloff as a buying opportunity ahead of a possible slowdown or yield reversal.

Armada Acquisition Corp. II is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combinations with one or more businesses. The company was founded on October 3, 2024 and is headquartered in Miami, FL.

Armada Acquisition Corp. II - Ordinary Shares- Class A

Evernorth Holdings Inc.

Evernorths progress toward a Nasdaq listing as an XRP treasury company is driving attention, with traders focused on merger approval and the companys planned XRP holdings. The news has fueled bullish speculation and interest in warrants, while others caution about SPAC and volatility risks.

Carnival Corp. Ltd. engages in the operation of cruise ships. It operates through the following business segments: North America Cruise Operations, Europe Cruise Operations, Cruise Support, and Tour and Others. The North America Cruise Operations segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corporation Ltd.

Carnival Corp

Carnivals quarterly results beat expectations and lifted its full-year outlook, with record bookings and strong cruise demand driving a sharp rally. Bulls welcomed the results and booking momentum, while skeptics pointed to fuel costs and softer fourth-quarter guidance as risks to sustaining the gains.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IRENs sustained selloff and underperformance are driving debate, with traders pointing to higher yields and weakness across data-center stocks while also criticizing dilution, execution and limited updates on AI contracts. B. Rileys lower price target added to the bearish discussion, though bulls argue the companys AI/HPC contracts support its longer-term prospects.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$BCTX https://sambasci.com/blog/briacell-bets-on-a-more-accessible-cell-therapy/?fbclid=IwVERDUAUoizhleHRuA2FlbQIxMABwZG9mBXNydGMGYXBwX2lkDDM1MDY4NTUzMTcyOAABHiB95uJ1ucglyDPv846T6IcsDIR0vcIFCHygCQ8MS1ursCChsLwHZA7pLOeZ_aem_pKa12YhbNu0C3wE04-EaZQ

Mark

Justin

Emerging therapeutic company BriaCell is combining the advantages of cell therapy without limitations in their newest clinical trial for cancer treatment.